Product Images Methylphenidate Hydrochloride

Not available.*

This text contains information about the importance of checking the risk for abuse, misuse, and addiction before starting treatment with methylphenidate hydrochloride chewable tablets. It also mentions the need for monitoring during treatment and the potential for physical dependence after prolonged use. The text advises against giving the tablets to anyone else and provides guidance on storing and disposing of the medication. Additionally, it suggests informing the healthcare provider about any history of alcohol abuse or dependence on prescription medicines or street drugs.*

This text discusses the potential risks and precautions associated with taking methylphenidate hydrochloride chewable tablets. The medication may increase the risk of sudden death, stroke, and heart attack in adults, as well as elevated blood pressure and heart rate. Individuals with pre-existing heart problems, heart defects, high blood pressure, or a family history of these issues should inform their healthcare provider. Before starting the medication, it is important for the healthcare provider to conduct a thorough evaluation of any potential heart problems. Additionally, regular monitoring of blood pressure and heart rate is recommended during treatment. If any signs of heart problems such as chest pain, shortness of breath, or fainting occur while taking the medication, immediate contact with the healthcare provider is advised.*

This text provides information about potential side effects and symptoms to watch out for when taking methylphenidate hydrochloride chewable tablets. It mentions that patients should be vigilant for any new or worsening mental symptoms or problems such as new or worse behavior and thought problems, bipolar illness, aggressive behavior or hostility, psychotic symptoms (such as hearing voices, believing untrue things, or being suspicious), or manic symptoms. It also advises individuals to disclose any existing mental problems or family history of suicide, bipolar illness, or depression to their healthcare provider. If any new or worsening mental symptoms occur, including seeing or hearing unreal things, believing unreal things, or being suspicious, individuals are advised to contact their healthcare provider promptly.*

This text provides important information for individuals taking methylphenidate hydrochloride chewable tablets. It advises individuals to inform their healthcare provider if they or their child experience numbness, pain, skin color change, or sensitivity to temperature in their fingers or toes. Additionally, individuals are instructed to contact their healthcare provider immediately if they or their child notice any unexplained wounds appearing on their fingers or toes while taking the medication.*

This text appears to be describing a list of symptoms. The symptoms listed include nervousness, stomach ache, decreased appetite, trouble sleeping, fast heart beat, dizziness, headache, nausea, and weight loss. These symptoms can be indicative of various conditions or illnesses. It is important to consult a medical professional for a proper diagnosis and treatment.*